Initiator Pharma Dividends and Buybacks
Dividend criteria checks 0/6
Initiator Pharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-7.1%
Buyback Yield
| Total Shareholder Yield | -7.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We're Not Worried About Initiator Pharma's (STO:INIT) Cash Burn
May 31
Health Check: How Prudently Does Initiator Pharma (STO:INIT) Use Debt?
Feb 27Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?
May 20Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?
Jan 06We're Not Worried About Initiator Pharma's (STO:INIT) Cash Burn
Oct 26We're Not Very Worried About Initiator Pharma's (NGM:INIT) Cash Burn Rate
Jun 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if INIT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INIT's dividend payments have been increasing.
Dividend Yield vs Market
| Initiator Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (INIT) | n/a |
| Market Bottom 25% (SE) | 1.6% |
| Market Top 25% (SE) | 4.9% |
| Industry Average (Biotechs) | 1.6% |
| Analyst forecast (INIT) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate INIT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INIT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate INIT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as INIT has not reported any payouts.